Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial
Xiaofeng Liang(Jinan University), Yu Wang(Chinese Center For Disease Control and Prevention), Zhijun Guo, Yuhui Zhang, Shao-Hong Yan(Inner Mongolia Comprehensive Disease Prevention and Control Center), Rongcheng Li(Lanzhou University), Ping‐Yu Chen(Lanzhou Institute of Husbandry and Pharmaceutical Sciences), Xuan-Lin Cui, Weidong Yin(Sinovac Biotech), Fangjun Li(Agro-Environmental Protection Institute), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), QI Feng-chun(Changchun Institute of Biological Products), Duo-Jia Feng(China National Biotechnology (China)), Kang An(Nanjing University of Chinese Medicine), Ze Chen(Jiangsu T-mab BioPharma (China)), Yuliang Zhao, Huaqing Wang(Population Health Research Institute), Chang-Jun Ju, Shengli Xia(Henan Provincial Center for Disease Control and Prevention), Jiang Wu(Beijing Center for Disease Prevention and Control), Junzhi Wang(Hunan Academy of Agricultural Sciences), Kunming Yan
Cited by 254
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k